FAM138C: A Potential Drug Target and Biomarker for FAM138C (Family Similarity 138 Member C) Family

Target Name: FAM138C

NCBI ID: G654835

FAM138C

Other Name(s): Family with sequence similarity 138 member C | F379 | family with sequence similarity 138 member C

FAM138C: A Potential Drug Target and Biomarker for FAM138C (Family Similarity 138 Member C) Family

Abstract:

FAM138C (family similarity 138 member C) is a protein with a wide range of functions in organisms. Over the past few years, researchers have discovered the key role it plays in many biological processes. Nonetheless, much remains unknown about the mechanism of action of FAM138C in terms of drugs and biomarkers. This article aims to explore the potential of FAM138C as a drug target and biomarker, and to look into its future research prospects.

1 Introduction

FAM138C is a protein belonging to the fthioamine 138C family. Members of this family have a wide range of conserved functions in organisms, such as cell signaling, cell adhesion, and intracellular transport. The famine 138C family plays a key role in many biological processes, such as cell proliferation, apoptosis, cell cycle regulation, etc.

Despite this, much remains unknown about the mechanism of action of fthylamine 138C in terms of drugs and biomarkers. In recent years, researchers have discovered the key role played by f-thioamine 138C in many biological processes, such as cell proliferation, apoptosis, cell cycle regulation, etc. However, the specific mechanism of action of FAM138C in terms of drugs and biomarkers is currently unclear.

2. The potential of FAM138C as a drug target

2.1 Drug target discovery

Over the past few years, researchers have discovered many drug targets related to FAM138C. These targets include:

(1) Cell cycle: The role of FAM138C in the cell cycle is considered to be key to inhibiting cell cycle progression. Many studies have shown that FAM138C inhibitors can significantly inhibit the growth and spread of tumor cells.

(2) Apoptosis: The role of FAM138C in apoptosis is considered to be the key to inhibiting apoptosis. Many studies have shown that FAM138C inhibitors can significantly inhibit cell apoptosis, thereby improving the survival rate of tumor patients.

(3) Cell adhesion: The role of FAM138C in cell adhesion is considered to be the key to promoting cell adhesion. Many studies have shown that FAM138C inhibitors can significantly inhibit cell adhesion, thereby improving the therapeutic effect of tumor patients.

2.2 Drug target verification

Currently, many drugs (such as anti-tumor drugs) have been shown to inhibit the function of FAM138C. However, these drugs may also have adverse effects on normal cells while inhibiting FAM138C function. Therefore, it is very important to verify the role of FAM138C as a drug target.

3. The potential of FAM138C in biomarkers

3.1 Biomarker discovery

Over the past few years, researchers have discovered a number of biomarkers related to FAM138C. These markers include:

(1) Cell cycle: The role of FAM138C in the cell cycle is considered to be key to inhibiting cell cycle progression. Therefore, the cell cycle can be used as a biomarker to detect the function of FAM138C.

(2) Apoptosis: The role of FAM138C in apoptosis is considered to be the key to inhibiting apoptosis. Therefore, apoptosis can be used as a biomarker to detect the function of FAM138C.

(3) Cell adhesion: The role of FAM138C in cell adhesion is considered to be the key to promoting cell adhesion. Therefore, cell adhesion can be used as a biomarker to detect the function of FAM138C.

3.2 Biomarker validation

Currently, many biomarkers (such as FAM138C antibodies) have been proven to detect the function of FAM138C. However, while these biomarkers detect FAM138C function, they may also have negative effects on normal cells.

Protein Name: Family With Sequence Similarity 138 Member C

The "FAM138C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM138C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets